Answers are grounded in this paper and cite their sources.
Thrombosthenin M was isolated from equine blood platelets by lysis of the platelets with n ‐butanol at pH 7.0 at low ionic strength ( I = 0.05), separation of the insoluble thrombosthenin by centrifugation, and extraction of thrombosthenin M from the sediment with 0.02 M pyrophosphate buffer pH 9.5. Contaminating ribonucleic acid was digested with ribonuclease and the protein finally purified by gel filtration on Sephadex G‐200. The purified thrombosthenin M was found to be free of thrombosthenin A and of fibrinogen. Thrombosthenin M, similarly to actin‐free muscle myosin, possesses a Ca ++ ‐activated but not a Mg ++ ‐activated ATPase activity, and shows neither a drop in viscosity nor superprecipitation on addition of ATP. Ultracentrifugal analysis of the thrombosthenin M preparation obtained (pH7.0, I = 0.6) revealed that about 90% of the protein sediments with a sedimentation coefficient of 7.2 S and about 10% with a sedimentation coefficient of 33 S. The thrombosthenin M preparation yielded a single band on disc electrophoresis; some of the protein failed, however, to penetrate the gel. Incubation of thrombosthenin M with thrombin resulted in the appearance of one mole of carboxyl terminal arginine per 10 5 g of thrombosthenin M. The ATPase activity of the thrombosthenin M was not affected by thrombin. Incubation of equine platelets with thrombin resulted in the disappearance of the electrophoretic band corresponding to thrombosthenin M. Antiserum against thrombosthenin M was found to inhibit the clot retraction of thrombin‐treated platelet‐rich plasma.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: